Portage Biotech Inc. (PRTG)

0.2400 +0.0188 (+8.50%) At close: 04:00PM EDT

Portage Biotech Inc.

Clarence Thomas Building
P.O. Box 4649 Road Town
Tortola VG1110
British Virgin Islands
203 221 7378
https://www.portagebiotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 7

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Ian B. Walters M.B.A., M.D.	CEO & Chairman of Board	967.65k	N/A	1968
Dr. Robert A. Kramer Ph.D.	Chief Scientific Officer	310.16k	N/A	N/A
Mr. Brian Wiley	Chief Business Officer	220.69k	N/A	1968
Mr. Justin Fairchild	Vice President of Development	283.83k	N/A	N/A
Mr. Joseph Ciavarella	Chief Accounting Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.

Corporate Governance

Portage Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.